Thanks for the nice, thought provoking analysis. It's good

New Post Public Reply Private Reply Replies (0) Message Board
kabonk TechGuru #80440
603
Thanks for the nice, thought provoking analysis. It's good to review this paper some more. A couple of things don't make sense to me.

One thing I missed on first glance was that RANTES/CCL5 no longer appeared to be abnormal in acute or chronic Covid, compared to Patterson's earlier report and claims that Covid is a RANTES disease, with very high RANTES/CCL5.

Table 1 lists normal RANTES level as ~10-12K pg/mL, and Covid showed only modestly elevated RANTES, averaging upper 11K in acute disease (m/m and s/c both), and 12.5K in chronic disease.

T1.medium.gif

Prior paper (Fig. 1d) showed normal as ~400 pg/mL, m/m as ~3K pg/mL, and s/c as ~40K of pg/mL. Maybe I am misreading the numbers, or they are measuring different things or with different assays?

F1.medium.gif

I wonder how he would explain the different numbers in controls, and the apparently less elevated levels of CCL5/RANTES in this acute Covid cohort compared to these (different) controls?

Do the numbers really support his claim that "Interestingly, COVID-19 individuals (including LH, mild, severe) show high levels of CCL5, a chemoattractant that like CCL4 signals through CCR5?" I don't see it stand out from the numbers in the table. I guess would need to see the statistics on that from this paper, which weren't presented.

The second thing is the low CCL4 levels in LH and the purported reduced recruitment of activated T-effector cells via CCR5 activation by reduced CCL4.

Quote:
Therefore, proper T cell activation (high IFN-γ+IL-2) but ineffective T cell recruitment (low CCL4) are characteristic features of the failed antiviral response observed in the LH group supporting virus persistence.


Patterson implies that LH have persistent viral infection that can't be cleared because activated T-effector cells don't have the proper migratory signals (CCL4 is low, although CCL5 he says is modestly higher).

How then will blocking CCL4 and CCL5 activation of CCR5 (via leronlimab) help? It should theoretically make this reduced recruitment/migration of T-effector cells worse, right? (Assuming that we want T-effector cells to be able to go where they are supposed to go to fight the infection).

Patterson then has us look at CCR1, saying CCL5 can activate it, CCL4 may be an antagonist of CCR1, that IFN-g upregulates CCR1 expression, and Covid patients have upregulated CCR1. Put that all together, and with slightly higher CCL5 and lower CCL4, LH would have increased recruitment of monocytes and neutrophils expressing CCR1.

Then what? Maybe these increased monocytes and neutrophils just promote the pro-inflammatory state that cause LH symptoms, all without resolution of the underlying (postulated) persistent viral infection or re-setting of the dysregulated immune state.

The rationale for targeting CCR5 in s/c Covid makes a lot more sense than in chronic disease/ LH / PASC.
________________________

Overall, I'd say the immunology of acute and chronic Covid is not well understood, especially by me! I just heard a lecture on the chronic neurological sequelae of Covid this week, and we are still in the early stages of figuring it all out.

It's interesting that Patterson claims 85% success in LH using combination of ivermectin, low dose steroids, and maraviroc. It will be great to see that treatment paper when it comes out, even though it won't be a blinded trial.

It will be good to see if leronlimab helps LHers, and to try to figure out how if it does. The trial should be starting soon.

More importantly, we are almost ready to see the CD12 results! (Hah, we are WAY past ready, but hopefully FDA and CYDY are ready for a big reveal).











CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 64

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 68

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 115

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 66

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 103

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Senior Living: The BrainFit Gym Experience

Updated Category News Views 330

Introducing the BrainFit Gym at The Bristal The Bristal Assisted Living is taking a bold step towards promoting cognitive wellness among seniors with their newly launched BrainFit Gym. Located at The Bristal at York Avenue, this unique facility stands out as a pioneering initiative aimed at enhancing the mental capacities of its residents. With this innovative approach,...

Continue Reading
Bullish (BLSH) Stock Surges After Thrilling IPO Success

Updated Category News Views 262

Bullish Stock Makes a Remarkable Entrance on the Market Recently, the cryptocurrency exchange Bullish (BLSH) took the public market by storm with its much-anticipated initial public offering (IPO). Its shares soared following trading debut, generating excitement among investors and analysts alike. Key Highlights of the IPO Supported by the renowned billionaire venture...

Continue Reading
Medius Honored as Top Microsoft Partner for Innovative Finance

Updated Category News Views 118

Medius Named 2024 Microsoft ISV Partner of the Year Medius, a leader in Accounts Payable (AP) Automation and Spend Management solutions, has reached an impressive milestone by being honored as the 2024 Microsoft ISV Partner of the Year. This esteemed award showcases Medius' dedication to innovation and excellence in improving finance operations through technology. The...

Continue Reading
Day One Biopharmaceuticals Set to Reveal Q1 2025 Financials

Updated Category News Views 309

Day One Biopharmaceuticals Plans Q1 2025 Financial Report Day One Biopharmaceuticals (NASDAQ: DAWN) is gearing up for a significant event. The biopharmaceutical company, known for its dedication to developing targeted therapies for serious illnesses, has announced a live conference call and webcast set for early May 2025. This event offers a chance for stakeholders to...

Continue Reading
Navigating the Future of Nonprofit Fundraising in 2025

Updated Category News Views 441

Nonprofit Fundraising Trends for 2025 As we approach the year 2025, nonprofits are setting their sights on innovative tactics that will not only enhance their fundraising efforts but also embrace the changing dynamics of donor engagement. Recent insights reveal that the landscape of nonprofit fundraising is evolving, making adaptability a core component of success in the...

Continue Reading